← Leaderboards
Carlos Iribarren
Kaiser Foundation Research Institute
$8,324,626
Attributed
$11,687,652
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2011–21$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$11,687,652 · 4
By mechanism
R01$9,995,697 · 3
P50$1,691,955 · 1
Top collaborators
- Sabee Y Molloi4 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Sascha Dublin$10,789,699
- Deborah E. Barnes$8,708,473
- Lawrence H Kushi$60,993,337
- Kelly Corinne Young-Wolff$8,959,572
- Assiamira Ferrara$36,823,631
Others in their field
Top investigators on “California”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$152,313,768
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Sharon A Nachman · Johns Hopkins University$135,132,510
Research focus
CaliforniaVariantCohortProgramsPopulation HeterogeneityGenesPharmacogenomicsGenetic EpidemiologyGenotypeParticipantGenome-WideBiobankAgingFutureDesignDiabetes MellitusMemberEnvironmentAdverse OutcomeBaseAdultGenome Wide Association StudyExposure ToPharmacy Facility
Grant awards (15)
Population-based pharmacogenomic assessment of QT prolongation$754,578
R01 · FY2021 · HL · contact PI
Population-based pharmacogenomic assessment of QT prolongation$754,578
R01 · FY2020 · HL · contact PI
Population-based pharmacogenomic assessment of QT prolongation$754,578
R01 · FY2019 · HL · contact PI
Clinical Core - Pharmacogenomics of Statin Therapy (POST)$160,159
P50 · FY2019 · GM · contact PI
Population-based pharmacogenomic assessment of QT prolongation$754,578
R01 · FY2018 · HL · contact PI
Clinical Core - Pharmacogenomics of Statin Therapy (POST)$146,323
P50 · FY2018 · GM · contact PI
Clinical Core - Pharmacogenomics of Statin Therapy (POST)$385,607
P50 · FY2017 · GM · contact PI
Clinical Core - Pharmacogenomics of Statin Therapy (POST)$508,733
P50 · FY2016 · GM · contact PI
Multiethnic Study of Breast Arterial Calcium Gradation and CVD$1,239,153
R01 · FY2015 · HL · contact PI
Clinical Core - Pharmacogenomics of Statin Therapy (POST)$491,133
P50 · FY2015 · GM · contact PI
Multiethnic Study of Breast Arterial Calcium Gradation and CVD$1,365,927
R01 · FY2014 · HL · contact PI
Multiethnic Study of Breast Arterial Calcium Gradation and CVD$2,179,612
R01 · FY2012 · HL · contact PI
Multiethnic Study of Breast Arterial Calcium Gradation and CVD$1,941,361
R01 · FY2011 · HL · contact PI
Cardiac and Renal Disease Study (CARDS)$126,292
R01 · FY2003 · HL
Cardiac and Renal Disease Study (CARDS)$125,040
R01 · FY2002 · HL